Compare TRVI & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRVI | KSS |
|---|---|---|
| Founded | 2011 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2019 | 1995 |
| Metric | TRVI | KSS |
|---|---|---|
| Price | $13.84 | $14.85 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 11 | 15 |
| Target Price | ★ $21.55 | $15.31 |
| AVG Volume (30 Days) | 1.6M | ★ 3.6M |
| Earning Date | 05-08-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 3.28% |
| EPS Growth | 31.91 | ★ 142.86 |
| EPS | N/A | ★ 2.38 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.21 |
| P/E Ratio | ★ N/A | $6.39 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.38 | $6.47 |
| 52 Week High | $16.12 | $25.22 |
| Indicator | TRVI | KSS |
|---|---|---|
| Relative Strength Index (RSI) | 54.32 | 53.54 |
| Support Level | $10.07 | $13.98 |
| Resistance Level | $13.97 | $16.95 |
| Average True Range (ATR) | 0.86 | 0.78 |
| MACD | -0.07 | 0.20 |
| Stochastic Oscillator | 30.40 | 54.06 |
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
Kohl's is the second-largest traditional US department store company by sales. It has about 1,150 stores in 49 states and offers moderately priced private-label (31% of 2025 sales) and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most (about 80%) of its stores are in strip centers. Kohl's also has a large digital sales operation (29% of 2025 sales). Women's apparel is the retailer's largest category, having generated 24% of its 2025 sales. Kohl's is headquartered in Menomonee Falls, Wisconsin, and was founded in 1962.